Seroprevalence of Immunoglobulin G against measles and rubella over a 12-year period (2009–2021) in Kilifi, Kenya and the impact of the Measles-Rubella (MR) vaccine campaign of 2016

  1. C.N. Mburu
  2. J. Ojal
  3. R. Selim
  4. R. Ombati
  5. D. Akech
  6. B. Karia
  7. J. Tuju
  8. A. Sigilai
  9. G. Smits
  10. P.G.M. van Gageldonk
  11. F.R.M. van der Klis
  12. S. Flasche
  13. E.W. Kagucia
  14. J.A.G. Scott
  15. I.M.O. Adetifa
Read the full article

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

No abstract available

Article activity feed

  1. Version published to 10.1016/j.vaccine.2025.127425
  2. Version published to 10.1101/2025.02.11.25322096 on medRxiv